Exchange: NASDAQ·Updated 02:42 PM EST
SEPN logo

SEPN Septerna Inc.

$40.61
$0.59
(1.47%)
Today
Reported EarningsNov 9
Mkt Cap$1.9B
Vol135,505.00

About SEPN

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
34

Bearish Sentiment

How do you feel about SEPN?

Advertisement|Remove ads.